Compounds, formulations, and methods for ameliorating telangiectasias
US7838563B2 · kind B2 · utility
29Cited by
52References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2006 |
| Grant date | Nov 23, 2010 |
| Priority date | — |
| Expiry date | Sep 16, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, compounds, and topical formulations for treatment of telangiectasias are disclosed. The methods comprise topically applying a composition comprising an α-adrenergic receptor agonist to telangiectatic skin. Amelioration of telangiectasia symptoms begins within minutes after topical application of a disclosed composition. A single application can significantly lessen telangiectasia discoloration for at least about 2 hours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.